61.69
-1.575(-2.49%)
Currency In USD
| Previous Close | 63.26 |
| Open | 62.69 |
| Day High | 63.16 |
| Day Low | 61.64 |
| 52-Week High | 70.81 |
| 52-Week Low | 52.5 |
| Volume | 53,858 |
| Average Volume | 254,846 |
| Market Cap | 1.34B |
| PE | -59.31 |
| EPS | -1.04 |
| Moving Average 50 Days | 57.98 |
| Moving Average 200 Days | 59.5 |
| Change | -1.58 |
If you invested $1000 in ANI Pharmaceuticals, Inc. (ANIP) 10 years ago, it would be worth $1,022.46 as of March 13, 2025 at a share price of $61.685. Whereas If you bought $1000 worth of ANI Pharmaceuticals, Inc. (ANIP) shares 5 years ago, it would be worth $1,716.33 as of March 13, 2025 at a share price of $61.685.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
GlobeNewswire Inc.
Mar 03, 2025 9:30 PM GMT
PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified Cortrophin® Gel (repository corticotropin injection USP)
ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March
GlobeNewswire Inc.
Feb 19, 2025 9:30 PM GMT
PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and select members of senior management, will present a
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET
GlobeNewswire Inc.
Feb 18, 2025 9:05 PM GMT
PRINCETON, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2024 financial results on Friday, February 28, 2025,